Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway
Cited by 17
Related Papers
Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation
|International Journal of Molecular Medicine|2017|24